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Objectives: The purpose was to test the durability of the use of the unobstructed popliteal or tibial arteries as alternative 
inflow sources. 
Materials: We examined 106 such bypasses performed uring a 12 year period (1981-93). The indication for surgery was 
limb salvage in 99.1%. Seventy-five percent of the patients were male, 78% were diabetic and the average age was 59.6 
years. The inflow source was the above-knee popliteaI artery in I5 cases, the below-knee popliteal artery in 70 cases, the 
anterior tibiaI artery in 11 cases and the posterior tibial artery in 10 cases. Adequacy of inflow was determined by 
angiogram as well as intraoperative pressure measurement when indicated. Outflow was to a distal tibial or plantar arteries 
in 77.4% of the procedures. Forty-six bypasses were performed by an in situ technique.. Excised vein was used as conduit 
in 60 patients (56.6%); greater saphenous vein (38), lesser saphenous vein (10), cephatic/basilic vein (4), and spliced vein 
(8). 
Results: Operative mortality was 2.8%. Five year cumulative primary patency was 75.4% with a secondary patency of 
82.6%. Five year cumulative limb salvage was 93.5%. Patency rate was not significantly different for various inflows or 
outflows. Only four of the 106 bypasses ultimately required areconstruction from the femoral level for proximal progression 
of disease. Bypasses performed using an in situ technique showed a significantly better 5 year cumulative secondary 
patency rate (96.3%) than those done with excised vein (70.5%), p < .05. 
Conclusion: Results of this study indicate that use of the popliteal or tibiaI arteries as an inflow source in the absence of 
significant proximal disease carries acceptable r sults, especially when using the vein in situ. 
Key Words: Short bypasses; Limb salvage; PopliteaI to distal bypass. 
Introduction 
Although the common femoral artery has been the 
traditional inflow source for distal bypass procedures, 
the use of more distal inflow sources has been 
increasing with recognition of the durability of these 
i5 types of bypasses.-  The potential advantages of 
using a patent popliteal or tibial artery for inflow 
include decreased dissection and conservation of 
autogenous vein. The theoretical drawbacks of using a 
distal inflow Source include the presence of haemody- 
namically significant proximal occlusive disease (espe- 
cially in the superficial femoral artery) and progres- 
sion of occlusive disease in the postoperative period. 
This report documents our 12 year experience with 
popliteal or tibial based distal artery bypasses. 
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Of 2830 infrainguinal bypasses, a total of 106 popliteal 
or tibial to distal artery bypasses were performed in 95 
patients during the review period (1981-1993). 
Patients with a previous or simultaneous femor- 
opopliteal bypass were excluded from this analysis, as 
were patients operated on for trauma. Chronic critical 
ischaemia was the indication for surgery in 92 cases 
(86.8%). Acute ischaemia or acute ischaemia overlying 
a history of chronic ischaemia was the indication for 
surgery in 13 cases (12.3%). One  bypass was per- 
formed for claudication. 
Patient demographics are listed in Table 1. Of note is 
that the mean age of the patients was 59.6 years. 
Seventy-eight per cent were diabetic. 
Patients were usually considered for this type of 
bypass if there was no evidence of significant disease 
in the proximal arterial system as evidenced by both 
noninvasive testing and arteriography. In these 
patients, the use of a distal inflow source was chosen 
Materials and Methods 
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Table 1. Patient demographics and risk factors 
Male 79 (74.5%) 
Female 27 (25.5%) 
Age 59.6 years (15-86) 
Coronary artery disease 58 55.0% 
Hypertension 69 65.0% 
Diabetes mellitus 83 78.0% 
Renal failure 18 16.5% 
Smoking history 40 38.0 % 
preferentially in order to conserve autogenous vein. In 
22 cases, there was a suspicion of proximal disease at 
the time of surgery. The inflow in these cases was 
assessed by intra-arterial pressure measurement both 
prior to bypass and after completion of the bypass. A 
pressure drop of 10 mmHg or greater in comparison to 
the radial or brachial pressure was grounds for 
correction of the proximal disease; patients requiring a
simultaneous inflow procedure were deleted from this 
study. 
The inflow arteries used are listed in Table 2. The 
below-knee popliteal artery was used in the large 
majority of cases, whereas the anterior or posterior 
tibial arteries were used in 21 cases (19.8%). 
The outflow arteries used are listed in Table 3. The 
dorsalis pedis was used most frequently (36.7%). 
Almost all other outflow sites were within the distal 
third of the artery. In 35 cases (33%) pedal arches were 
absent. We did not measure peripheral resistance in 
these cases. 
While only 11 bypasses (10.4%) in the entire group 
were performed in patients with a previous ipsilateral 
distal bypass, there were an additional eight bypasses 
performed in limbs lacking greater saphenous vein 
due to previous tripping or harvesting for coronary 
arterial bypass procedures. 
In selecting the type of bypass, use of the ipsilateral 
greater saphenous vein (GSV) was preferred. If the 
below-knee portion of the GSV was large, it was 
prepared in situ with the modified Mills valvulotome. 
If the above-knee portion of the GSV was considerably 
larger, this segment was usually used. In patients 
lacking adequate GSV, the lesser saphenous vein was 
used in 17 cases, arm vein in four, and spliced vein 
segments in eight. Of the 60 procedures performed 
with excised vein, 26 (43.3%) were placed in an 
orthograde direction and the valves incised with the 
modified Mills valvulotome while the remaining 34 
Table 2. Inflow arteries 
Above-knee popliteal 15 14.2% 
Below-knee popliteal 70 66.0 % 
Anterior tibial 11 10.4% 
Posterior tibial 10 9.4% 
Table 3. Outflow arteries 
n Total Percentage 
Anterior 7fibial 23 21.7 
Proximal 2 
Mid 7 
Distal 14 
Posterior tibial 20 18.9 
Proximal 0 
Mid 6 
Distal 14 
Peroneal 22 20.8 
Proximal 2 
Mid 7 
Distal 13 
Dorsalis pedis 39 36.7 
Plantar 2 1.9 
Table 4. Types of conduits 
n Total 
In situ bypass 46 
Greater saphenous vein 39 
Lesser saphenous vein 7 
Excised vein 60 
Greater saphenous vein 28 
Lesster saphenous vein 10 
Cephalic/basilic 4 
Spliced 8 
(56.7%) were placed in a reversed configuration. An 
orthograde configuration was selected whenever there 
was a subjectively arge proximal-to-distal per of the 
vein segment in question. The distribution of the types 
of conduits used is listed in Table 4. Veins with 
external diameters of less than 3.0 mm were not used. 
In two patients primary amputations were done 
because of no run-off arteries. 
Follow-up of these bypasses was accomplished with 
physical examination, pulse volume recordings, seg- 
mental pressures, and Duplex ultrasonography within 
the first month postoperatively, every 3 months for the 
first year, and every 6 to 12 months thereafter. 
Data was analysedand presented in life-table form 
according to the recommendations of the Ad Hoc 
Committee of the SoCiety of Vascular Surgery. 6 
Results 
There were three deaths (2.8%) within 30 days of the 
operation, all from myocardial infarction. Major post- 
operative complications included nonfatal myocardial 
infarction in four patients (3.8%), stroke in two (1.9%) 
and wound edge necrosis or infection in five (4.7%). 
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Table 5. Primary graft patency 
Interval Interval Cumulative Standard 
(months) No. at risk Revisions Withdrawn patency patency error % 
0- i 106 9 13 (3) 0.907 0.907 2.7 
2-12 79 9 20 (9) 0.855 0.775 4.1 
13-24 36 1 12 (8) 0.966 0.749 6.3 
25-36 22 0 7 (6) 1.000 0.749 8.0 
37-48 15 0 5 (4) 1.000 0.749 9.7 
49-60 10 0 3 (3) 1.000 0.749 (11.8) 
( )=Number dead. 
Table 6. Secondary graft patency 
Interval Interval Cumulative Standard 
(months) No. at risk Revisions Withdrawn patency patency error % 
0- 1 106 6 13 (3) 0.983 0.983 2.3 
2-12 82 6 20 (9) 0.907 0.851 3.6 
13-24 41 1 12 (8) 0.971 0.826 5.4 
25-36 26 0 7 (6) 1.000 0.826 6.8 
37-48 18 0 5 (4) 1.000 0.826 8.1 
49-60 11 0 3 (3) 1.000 0.826 10.3 
( )=Number dead. 
Table 7. Limb salvage 
Interval Interval Cumulative Standard 
(months) No. at r i sk  Amputat ions  Withdrawn patency patency error % 
0-1 106 2 14 (3) 0.979 0.979 1.4 
2-12 84 3 22 (9) 0.953 0.933 2.6 
13-24 42 0 13 (8) 1.000 0.933 3.7 
25-36 26 0 8 (6) 1.000 0.933 4.7 
37-48 18 0 5 (4) 1.000 0.933 6.0 
49-60 11 0 3 (3) 1.000 0.933 7.3 
( )=Number dead. 
Cumulative 5 year mortality was 53%, which was 
similar to that of all infrainguinal bypasses. 
Cumulative life-table primary graft patency was 
90.7% at 1 year and 74.9% at 2 to 5 years as seen in 
Table 5. Cumulative secondary graft patenc)~ as 
shown in Table 6, was 93.8% at one year and 82.6% at 
2 to 5 years postoperatively. Average follow-up was 
17.6 months (range 1-108 months). Limb salvage is 
presented in Table 7. There were five major amputa- 
tions in this group, two from bypass occlusion and 
three with persistent nonhealing lesions in spite of a 
patent bypass. This latter group were comprised of 
one patient with diabetes and two patients with renal 
failure and diabetes. 
There were 13 bypass occlusions in this series; 12 of 
these occlusions occurred in the excised vein group 
while there was only one occlusion in the in situ 
group. These 13 occlusions were caused by progres- 
sion of inflow disease in six cases, all in the group of 22 
patients with prior angiographic evidence of proximal 
disease. Nine limbs were rebypassed and salvaged; 
four of these were based from the femoral artery. Two 
patients with an occluded bypass required no further 
surgery. 
There were two patients who required revision to a 
more distal outflow site. There was one bypass 
stenosis treated with a vein patch angioplasty. One 
stenosis in the donor artery was treated with trans- 
luminal angioplasty. One in situ bypass required 
ligation of a fistula. One bypass occluded, probably 
due to embolisation, and was successfully revised 
with catheter embolectomy. 
The results were analysed in regards to several 
factors which might be thought to affect patency. 
These are presented in Table 8. None of the other 
factors, such as diabetes, presence or absence of pedal 
arch, or gender had any effect on the outcome. The use 
of excised veins and the presence of inflow disease 
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Table 8. Cumulative secondary patency - sub-groups 
I year 5 year p value 
Tibial outflow 0.810 0.810 NS 
Pedal outflow 0.907 0.852 NS 
In situ vein 0.967 0.967 0.003 
Excised vein 0.741 0.695 0.003 
was associated with significantly lowered patency 
rates. Use of the dorsalis pedis artery as an outflow 
vessel was not associated with decreased bypass 
patency. Ankle brachial index (ABI) increased from 
pre-operative values of 0.31 + 0.11 to 0.86 + 0.20 
(p < 0.05). 
Discussion 
Use of the popliteal and tibial arteries for inflow 
sources has been described in several reports, both as 
a part of a larger series 1'2 and smaller series dealing 
exclusively with these bypasses. 3-s'7-1~ The results 
presented in these series demonstrate hat, in general, 
use of the popliteal and tibial arteries for inflow 
compares favourably with the use of the femoral 
artery.~,2,~2,13 
Given the overall positive results in the afore- 
mentioned reports, what are the limitations of this 
type of operation? In the current series, 84 procedures 
were performed in patients with no angiographic 
evidence of more proximal occlusive disease; in this 
group there were only six bypass occlusions, none 
from progression of proximal disease. In particular, 
the 46 bypasses performed by the in situ technique, all 
of whom had no inflow disease, had only one 
occlusion in follow-up. Thus in cases in which an in 
situ technique is possible and in which an undiseased 
popliteal artery is available for inflow, there appears to 
be minimal risk of proximal disease progression, and 
is to be preferred to the more typical femorotibial 
bypass. 
On the other hang there is the more difficult type of 
patient in whom there is some evidence of proximal 
occlusive disease. In this series, the haemodynamic 
adequacy of the popliteal or tibial artery was con- 
firmed with intra-arterial pressure measurements. 
Patients with a gradient of 10 mmHg or greater were 
excluded from this study and were managed by either 
a proximal bypass or percutaneous transluminal 
angioplasty (PTA) of the proximal arter3~ as described 
by Wengerter et al. 3 The results with composite 
sequential bypass may be somewhat less than the 
14 15 other options, ' whereas the results of a longer 
autogenous bypass are at least equivalent to the PTA/ 
distal bypass group. 1'2'12"13 Therefore these patients 
were excluded from this series. 
There was a group of 22 patients in whom there was 
angiographic evidence of proximal occlusive disease 
but there was no measurable gradient at the comple- 
tion of the bypass. These bypasses were usually 
performed in an effort to conserve vein or because 
there was insufficient vein to complete a longer bypass 
without splicing. There was evidence of proximal 
disease progression leading to bypass occlusion in six 
cases and an additional case of inflow stenosis treated 
with PTA. Thus, seven of 22 cases (31.8%) with a non- 
haemodynamically significant proximal occlusive dis- 
ease later developed significant proximal disease. It 
would seem that bypasses in this group perform less 
well and should at least be more closely monitored in 
the postoperative period as occlusion is more likely. 
However, in those cases in which there is so little 
available autogenous vein as to preclude any other 
option, use of a compromised inflow is acceptable. 
The use of veins of less than 3.0 mm external 
diameter has been associated with decreased bypass 
patency; we avoided using such veins due to this data 
as well as that derived from a larger series of in situ 
bypasses. 3"16 Wengerter et al. 3 have also reported that 
use of the dorsalis pedis artery as an outflow vessel 
was associated with decreased bypass patency; this 
was not the case in this series. The differences in these 
results may either be due to the preferential use of the 
in situ technique or larger excised veins when availa- 
ble, but is impossible to directly confirm at this time. 
In conclusion, the angiographically undiseased 
popliteal or tibial artery may be used for bypass 
inflow with expectations of excellent long-term 
patenc3~ especially when an in situ technique is 
possible. Use of a popliteal or tibial inflow below 
angiographically evident but haemodynamically 
undetectable occlusive disease may be associated with 
a higher rate of occlusion that is acceptable only if no 
longer autogenous bypass is possible. 
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